Feel Therapeutics (FKA Sentio Solutions) is developing Digital Biomarkers and Therapeutics to bring objective data and measurement in how we diagnose, manage and care for Mental Health. The company is backed by top-tier investors (Felicis, Anthemis, SOSV) and partners with large Pharmaceuticals to develop novel digital biomarkers and bring digital health solutions to market as standalone therapeutics (DTx) or alongside medications. Find out more about Feel at www.feeltherapeutics.com or contact us at info@feeltherapeutics.com